Cargando…
Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria
BACKGROUND: Dental caries is the most prevalent oral disease in several Asian and Latin American countries. It is an infectious disease and different types of bacteria are involved in the process. Synthetic antimicrobials are used against this disease; however, many of these substances cause unwarra...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295328/ https://www.ncbi.nlm.nih.gov/pubmed/25495921 http://dx.doi.org/10.1186/1472-6882-14-478 |
_version_ | 1782352827437285376 |
---|---|
author | Franca, Juçara R De Luca, Mariana P Ribeiro, Tatiana G Castilho, Rachel O Moreira, Allyson N Santos, Vagner R Faraco, André AG |
author_facet | Franca, Juçara R De Luca, Mariana P Ribeiro, Tatiana G Castilho, Rachel O Moreira, Allyson N Santos, Vagner R Faraco, André AG |
author_sort | Franca, Juçara R |
collection | PubMed |
description | BACKGROUND: Dental caries is the most prevalent oral disease in several Asian and Latin American countries. It is an infectious disease and different types of bacteria are involved in the process. Synthetic antimicrobials are used against this disease; however, many of these substances cause unwarranted undesirable effects like vomiting, diarrhea and tooth staining. Propolis, a resinous substance collected by honeybees, has been used to control the oral microbiota. So, the objective of this study was to develop and characterize sustained-release propolis-based chitosan varnish useful on dental cariogenic biofilm prevention, besides the in vitro antimicrobial activity. METHODS: Three formulations of propolis - based chitosan varnish (PCV) containing different concentrations (5%, 10% and 15%) were produced by dissolution of propolis with chitosan on hydro-alcoholic vehicle. Bovine teeth were used for testing adhesion of coatings and to observe the controlled release of propolis associated with varnish. It was characterized by infrared spectroscopy, scanning electron microscopy, casting time, diffusion test in vitro antimicrobial activity and controlled release. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were tested for the main microorganisms involved in the cariogenic biofilm through the microdilution test in 96-well plates. RESULTS: The formulations presented a tooth surface adherence and were able to form films very fast on bovine tooth surface. Also, propolis-based chitosan varnishes have shown antimicrobial activity similar to or better than chlorhexidine varnish against all oral pathogen bacteria. All microorganisms were sensitive to propolis varnish and chitosan. MIC and MBC for microorganisms of cariogenic biofilme showed better results than chlorhexidine. Propolis active components were released for more than one week. CONCLUSION: All developed formulations turn them, 5%, 10% and 15% propolis content varnish, into products suitable for clinical application on dental caries prevention field, deserving clinical studies to confirm its in vivo activity. |
format | Online Article Text |
id | pubmed-4295328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42953282015-01-16 Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria Franca, Juçara R De Luca, Mariana P Ribeiro, Tatiana G Castilho, Rachel O Moreira, Allyson N Santos, Vagner R Faraco, André AG BMC Complement Altern Med Research Article BACKGROUND: Dental caries is the most prevalent oral disease in several Asian and Latin American countries. It is an infectious disease and different types of bacteria are involved in the process. Synthetic antimicrobials are used against this disease; however, many of these substances cause unwarranted undesirable effects like vomiting, diarrhea and tooth staining. Propolis, a resinous substance collected by honeybees, has been used to control the oral microbiota. So, the objective of this study was to develop and characterize sustained-release propolis-based chitosan varnish useful on dental cariogenic biofilm prevention, besides the in vitro antimicrobial activity. METHODS: Three formulations of propolis - based chitosan varnish (PCV) containing different concentrations (5%, 10% and 15%) were produced by dissolution of propolis with chitosan on hydro-alcoholic vehicle. Bovine teeth were used for testing adhesion of coatings and to observe the controlled release of propolis associated with varnish. It was characterized by infrared spectroscopy, scanning electron microscopy, casting time, diffusion test in vitro antimicrobial activity and controlled release. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were tested for the main microorganisms involved in the cariogenic biofilm through the microdilution test in 96-well plates. RESULTS: The formulations presented a tooth surface adherence and were able to form films very fast on bovine tooth surface. Also, propolis-based chitosan varnishes have shown antimicrobial activity similar to or better than chlorhexidine varnish against all oral pathogen bacteria. All microorganisms were sensitive to propolis varnish and chitosan. MIC and MBC for microorganisms of cariogenic biofilme showed better results than chlorhexidine. Propolis active components were released for more than one week. CONCLUSION: All developed formulations turn them, 5%, 10% and 15% propolis content varnish, into products suitable for clinical application on dental caries prevention field, deserving clinical studies to confirm its in vivo activity. BioMed Central 2014-12-12 /pmc/articles/PMC4295328/ /pubmed/25495921 http://dx.doi.org/10.1186/1472-6882-14-478 Text en © Franca et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Franca, Juçara R De Luca, Mariana P Ribeiro, Tatiana G Castilho, Rachel O Moreira, Allyson N Santos, Vagner R Faraco, André AG Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria |
title | Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria |
title_full | Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria |
title_fullStr | Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria |
title_full_unstemmed | Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria |
title_short | Propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria |
title_sort | propolis - based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295328/ https://www.ncbi.nlm.nih.gov/pubmed/25495921 http://dx.doi.org/10.1186/1472-6882-14-478 |
work_keys_str_mv | AT francajucarar propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria AT delucamarianap propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria AT ribeirotatianag propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria AT castilhorachelo propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria AT moreiraallysonn propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria AT santosvagnerr propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria AT faracoandreag propolisbasedchitosanvarnishdrugdeliverycontrolledreleaseandantimicrobialactivityagainstoralpathogenbacteria |